BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 23424108)

  • 1. Predictive systems biology approach to broad-spectrum, host-directed drug target discovery in infectious diseases.
    Felciano RM; Bavari S; Richards DR; Billaud JN; Warren T; Panchal R; Krämer A
    Pac Symp Biocomput; 2013; ():17-28. PubMed ID: 23424108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving drug discovery with contextual assays and cellular systems analysis.
    Westwick JK; Lamerdin JE
    Methods Mol Biol; 2011; 756():61-73. PubMed ID: 21870220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics and systems biology: application in drug discovery and development.
    Chakravarti B; Mallik B; Chakravarti DN
    Methods Mol Biol; 2010; 662():3-28. PubMed ID: 20824464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic network modeling and simulation for drug targeting and discovery.
    Kim HU; Sohn SB; Lee SY
    Biotechnol J; 2012 Mar; 7(3):330-42. PubMed ID: 22125297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of drug candidates and repurposing opportunities through compound-target interaction networks.
    Cichonska A; Rousu J; Aittokallio T
    Expert Opin Drug Discov; 2015 Dec; 10(12):1333-45. PubMed ID: 26429153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying systems biology in drug discovery and development.
    Galizzi JP; Lockhart BP; Bril A
    Drug Metabol Drug Interact; 2013; 28(2):67-78. PubMed ID: 23612649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network and pathway analysis of compound-protein interactions.
    Brennan RJ; Nikolskya T; Bureeva S
    Methods Mol Biol; 2009; 575():225-47. PubMed ID: 19727618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug target identification in sphingolipid metabolism by computational systems biology tools: metabolic control analysis and metabolic pathway analysis.
    Ozbayraktar FB; Ulgen KO
    J Biomed Inform; 2010 Aug; 43(4):537-49. PubMed ID: 20348024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unveiling the role of network and systems biology in drug discovery.
    Pujol A; Mosca R; Farrés J; Aloy P
    Trends Pharmacol Sci; 2010 Mar; 31(3):115-23. PubMed ID: 20117850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems biology in drug discovery.
    Butcher EC; Berg EL; Kunkel EJ
    Nat Biotechnol; 2004 Oct; 22(10):1253-9. PubMed ID: 15470465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems biology of tuberculosis.
    Chandra N; Kumar D; Rao K
    Tuberculosis (Edinb); 2011 Sep; 91(5):487-96. PubMed ID: 21459043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image-based systems biology of infection.
    Medyukhina A; Timme S; Mokhtari Z; Figge MT
    Cytometry A; 2015 Jun; 87(6):462-70. PubMed ID: 25641512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel paradigm for potential drug-targets discovery: quantifying relationships of enzymes and cascade interactions of neighboring biological processes to identify drug-targets.
    Chen L; Wang Q; Zhang L; Tai J; Wang H; Li W; Li X; He W; Li X
    Mol Biosyst; 2011 Apr; 7(4):1033-41. PubMed ID: 21270979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From workstations to workbenches: Towards predicting physicochemically viable protein-protein interactions across a host and a pathogen.
    Ramakrishnan G; Chandra NR; Srinivasan N
    IUBMB Life; 2014 Nov; 66(11):759-74. PubMed ID: 25512108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network systems biology for drug discovery.
    Arrell DK; Terzic A
    Clin Pharmacol Ther; 2010 Jul; 88(1):120-5. PubMed ID: 20520604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systems biology impact on antiepileptic drug discovery.
    Margineanu DG
    Epilepsy Res; 2012 Feb; 98(2-3):104-15. PubMed ID: 22055355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice.
    Liu H; Wang J; Zhou W; Wang Y; Yang L
    J Ethnopharmacol; 2013 Apr; 146(3):773-93. PubMed ID: 23415946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.
    Zhang Q; Bhattacharya S; Andersen ME; Conolly RB
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):253-76. PubMed ID: 20574901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of systems pharmacology in drug discovery.
    Cucurull-Sanchez L; Spink KG; Moschos SA
    Drug Discov Today; 2012 Jul; 17(13-14):665-70. PubMed ID: 22405899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.